On behalf of Cardinal Spine, PaxMed International received FDA 510(k) clearance of the C-VBR vertebral body replacement—reportedly the second cervical vertebral body replacement device to be cleared by FDA and the first such device designed with no possibility of reduction in height after surgery.
This clearance marks a milestone for PaxMed International, in that it is the consulting firm’s 180th 510(k) clearance.
NuVasive received FDA 510(k) clearance to market the X-Core® Mini Cervical Corpectomy System, reportedly the 1st clearance of a cervical corpectomy cage, in September 2015.
On behalf of Cardinal Spine, PaxMed International received FDA 510(k) clearance of the C-VBR vertebral body replacement—reportedly the second cervical vertebral body replacement device to be cleared by FDA and the first such device designed with no possibility of reduction in height after surgery.
On behalf of Cardinal Spine, PaxMed International received FDA 510(k) clearance of the C-VBR vertebral body replacement—reportedly the second cervical vertebral body replacement device to be cleared by FDA and the first such device designed with no possibility of reduction in height after surgery.
This clearance marks a milestone for PaxMed International, in that it is the consulting firm’s 180th 510(k) clearance.
NuVasive received FDA 510(k) clearance to market the X-Core® Mini Cervical Corpectomy System, reportedly the 1st clearance of a cervical corpectomy cage, in September 2015.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
